From Screening to Pharmacology: Lead Optimization of a CDK2 Molecular Glue Degrader
- Mapping the journey from screening to hit identification for a CDK2 molecular glue degrader
- Defining and monitoring critical parameters during lead optimization to ensure biological relevance
- Translating early activity into downstream pharmacology to achieve the desired therapeutic profile